Is Donegal Group Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: DGICA) stock is to Hold DGICA stock.
Out of 1 analyst, 0 (0%) are recommending DGICA as a Strong Buy, 0 (0%) are recommending DGICA as a Buy, 1 (100%) are recommending DGICA as a Hold, 0 (0%) are recommending DGICA as a Sell, and 0 (0%) are recommending DGICA as a Strong Sell.
What is DGICA's earnings growth forecast for 2025-2025?
(NASDAQ: DGICA) Donegal Group's forecast annual earnings growth rate of -50.21% is not forecast to beat the US Insurance - Property & Casualty industry's average forecast earnings growth rate of -5.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.97%.
Donegal Group's earnings in 2025 is $82,825,218.
In 2025, DGICA is forecast to generate $43,810,355 in earnings, with the lowest earnings forecast at $43,810,355 and the highest earnings forecast at $43,810,355.
What is DGICA's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: DGICA) forecast ROE is 8.44%, which is considered weak.
What is DGICA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year DGICA price target, the average DGICA price target is $18.00, with the highest DGICA stock price forecast at $18.00 and the lowest DGICA stock price forecast at $18.00.
The Wall Street analyst predicted that Donegal Group's share price could reach $18.00 by Apr 25, 2026. The average Donegal Group stock price prediction forecasts a potential upside of 3.57% from the current DGICA share price of $17.38.
What is DGICA's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: DGICA) Donegal Group's current Earnings Per Share (EPS) is $2.41. In 2025, DGICA's EPS is forecast to hit $1.20 (min: $1.20, max: $1.20).
What is DGICA's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: DGICA) forecast ROA is 2.12%, which is lower than the forecast US Insurance - Property & Casualty industry average of 5.19%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.